A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 31
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LX
Long Form : Lipoxins
No. Year Title Co-occurring Abbreviation
2020 The Lipoxin Receptor/FPR2 Agonist BML-111 Protects Mouse Skin Against Ultraviolet B Radiation. SPMs
2017 Lipoxin A4 selectively programs the profile of M2 tumor-associated macrophages which favour control of tumor progression. TAM
2016 Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection. Cne, LXA4
2015 Lipoxin A4 attenuates endothelial dysfunction during experimental cerebral malaria. BBB, CM, ECM, Pb, Pf, RBCs
2014 ATL-1, a synthetic analog of lipoxin, modulates endothelial permeability and interaction with tumor cells through a VEGF-dependent mechanism. EC, VEGF
2014 Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. sEH, sEHI
2014 Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. 15-HETE, TLR4
2009 ATLa, an aspirin-triggered lipoxin A4 synthetic analog, prevents the inflammatory and fibrotic effects of bleomycin-induced pulmonary fibrosis. ATL, BLM
2009 Lipoxin A4 inhibits IL-1beta-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells. ---
10  2009 Lipoxin A4: anti-inflammatory and anti-angiogenic impact on endothelial cells. VEGF
11  2007 Protective effects of BML-111, a lipoxin A(4) receptor agonist, on carbon tetrachloride-induced liver injury in mice. HO-1, MDA, TNF-alpha
12  2006 Lipid mediators: lipoxin and aspirin-triggered 15-epi-lipoxins. ATL, COX, LO
13  2005 Involvement of the Rho-kinase/myosin light chain kinase pathway on human monocyte chemotaxis induced by ATL-1, an aspirin-triggered lipoxin A4 synthetic analog. ATL-1, MLCK
14  2005 Lipoxin signaling in neutrophils and their role in periodontal disease. ---
15  2005 Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. ATL, ATL-1, EC, HO-1
16  2004 Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. ATL
17  2004 Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells. GPCR, MC, PDGF
18  2003 Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. ---
19  2003 Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. PMN
20  2003 Physical exercise increases urinary excretion of lipoxin A4 and related compounds. ---
21  2002 Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. ---
22  2002 Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. ATL, GN, PMN, PSR
23  2002 Polyisoprenyl phosphates: natural antiinflammatory lipid signals. PSDP
24  2001 Lipoxins and aspirin-triggered 15-epi-lipoxins are endogenous components of antiinflammation: emergence of the counterregulatory side. ---
25  2000 Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. PMN
26  2000 Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression. TF
27  2000 Lipoxins: novel anti-inflammatory therapeutics? ---
28  1999 Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. ---
29  1997 Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. ---
30  1995 Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. ---
31  1990 Lipoxin A4 inhibits phosphoinositide hydrolysis in human neutrophils. ---